Diagnosis and treatment of primary lymphedema consensus document of the international union of phlebology (IUP)-2013

International Angiology

Volumn 32, Issue 6, 2013, Pages 541-574

  Lee, B B ^a   Andrade, M ^b   Antignani, P L ^c   Boccardo, F ^d   Bunke, N ^e   Campisi, C ^d   Damstra, R ^f   Flour, M ^g   Forner Cordero, I ^h   Gloviczki, P ⁱ   Laredo, J ^j   Partsch, H ^m   Piller, N ^p   Michelini, S ^k   Mortimer, P ^l   Rabe, E ^q   Rockson, S ^r   Scuderi, A ⁿ   Szolnoky, G ^o   Villavicencio, J L ^s  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Vascular Center   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NIJ SMELLINGHE HOSPITAL   (Netherlands)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁱ Mayo Clinic   (United States)

^j GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^k MOLINETTE HOSPITAL   (Italy)

^l ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^m WILHELMINEN HOSPITAL   (Austria)

ⁿ PONTIFÍCIA UNIVERSIDADE CATÓLICA DE SÃO PAULO   (Brazil)

^o UNIVERSITY OF SZEGED   (Hungary)

^p FLINDERS UNIVERSITY   (Australia)

^q UNIVERSITY OF BONN   (Germany)

^r STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s WALTER REED ARMY MEDICAL CENTER   (United States)

more..

Author keywords

Ablative surgery; Compliance; Compression therapy; Decongestive Lymphatic Therapy; Gene oriented management; Primary lymphedema; Reconstructive surgery; Truncular lymphatic malformation

Indexed keywords

CHRONIC DISEASE; COMBINED MODALITY THERAPY; CONSENSUS; DRAINAGE; EVIDENCE-BASED MEDICINE; HUMANS; LYMPHEDEMA; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84894223284     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (293)

1. Guyatt GH, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, et al: Grading strength of recommendations and quality of evidence in clinical guidelines. Chest 2006; 129;174-181.
2. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, et al: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.
3. The diagnosis and treatment of peripheral lymphedema: Consensus document of the International Society of Lymphology. Lymphology 2003;36(2):84-91.
4. 2009 Consensus Document of the International Society of lymphology: The diagnosis and Treatment of Peripheral Lymphedema. Lymphology 2009; 42:51-60.
5. nd Edition 2012. www.lympho.org
6. Campisi C, Michelini S, Boccardo F. Guidelines of the Italian Society of Lymphology 2004;37(4):182-4.
7. Mortimer PS. Therapy approaches for lymphedema. Angiology. 1997;48(1):87-91.
8. Foldi E. The treatment of lymphedema. Cancer. 1998;83(12):2833-4.
9. Leduc O, Leduc A, Bourgeois P. Belgrado JP. The physical treatment of upper limb edema. American Cancer Society Lymphedema Workshop; Cancer 1998;83(12):2835-2839.
10. Szolnoky G, Lakatos B, Keskeny T, Dobozy A. Advantage of combined decongestive lymphatic therapy over manual lymph drainage: a pilot study. Lymphology 2002;35(1):277-282.
11. Rockson SG, Miller LT, Senie R et al. American cancer society lymphoedema workshop, workgroup iii: diagnosis and management of lymphoedema. Cancer 1998; 83 (12): 2882-5.
12. Lee BB, Kim YW, Kim DI, Hwang JH, Laredo J, Neville R: Supplemental surgical treatment to end stage (stage IV-V) of chronic lymphedema. Int Angiol. 2008; 27(5):389-95.
13. Baumeister RGH, Siuda S. Treatment of lymphedemas by microsurgical lymphatic grafting: what is proved? Plastic and Reconstructive Surgery 1990;85:64-74.
14. Campisi C, Boccardo F, Zilli A, Maccio A, Gariglio A, Schenone F. Peripheral lymphedema: new advances in microsurgical treatment and long-term outcome. Microsurgery. 2003;23(5):522-5.
15. Evans AL, Bell R, Brice G, Comeglio P, Lipede C, Jeffery S, Mortimer P, Sarfarazi M, Child AH. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J. Med. Genet. 2003;40: 697-703
16. Brice G, Mansour S, Bell R, Collin JRO, Child A H, Mortimer P, et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J. Med. Genet. 2002;39: 478-483
17. Burnand KG, Mortimer PS. Lymphangiogenesis and genetics of lymphoedema. In: Browse N, Burnand KG, Mortimer PS, editors. Diseases of the lymphatics. London: Arnold; 2003. pp. 102-9.
18. Witte MH, Erickson R, Reiser FA, Witte CL. Genetic alterations in lymphedema. Phlebolymphology 1997;16:19-25.
19. Bruna J, Miller AJ, Beninson J. The clinical grading and simple classification of lymphedema. Lymphology 2002;35:160-162.
20. Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998;3(2): 145-56.
21. Connell F, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer P, Mansour S, Ostergaard P. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013. Apr 26. doi: 10.1111/cge.12173. (Epub).
22. Levick JR, Michel CC, Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010;87:198-210.
23. Levick JR. An introduction to cardiovascular physiology 5th edition, 2010; Hodder Arnold, London pp 204-12.
24. Stanton AW, Patel HS, Levick JR, et al. Increased dermal lymphatic density in human leg compared with forearm. Microvasc Res 1999; 57: 320-328.
25. Olszewski WL, Engeset A. Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. Am J Physiol 1980;239:775-783.
26. Tanaka H, Zaima N, Sasaki T, Yamamoto N, Sano M, Konno H, Setou M, Unno N. Loss of lymphatic vessels and regional lipid accumulation is associated with great saphenous vein incompetence. J Vasc Surg 2012;55:1440-1448
27. Dennis, R Haemodynamics of Lymphoedema. Journal of Lymphoedema 2008; 3(2): 45-49
28. Rockson SG. Lymphedema. Am J Med. 2001;110(4):288-95.
29. Lammie PJ, Cuenco KT, Punkosdy GA. The pathogenesis of filarial lymphedema: is it the worm or is it the host? Ann N Y Acad Sci. 2002;979:131-42; discussion 188-96.
30. Lee BB: Lymphoedeme post-chirurgical: un terme frappe d'interdiction pour les chirurgiens. Angeilogie 2004;6(4):7-8.
31. Bernas MJ, Witte CL, Witte MH. The diagnosis and treatment of peripheral lymphedema. Lymphology 2001;34:84-91.
32. Lee BB, Seo JM, Hwang JH, Do YS, Kim DI, Byun HS, et al: Current concepts in lymphatic malformation (LM). J. VascEndovasc Surg 2005;39(1):67-81.
33. Lee BB: Lymphedema-Angiodysplasia Syndrome: a Prodigal form of Lymphatic Malformation (LM). Phlebolymphology 2005; 47:324-332.
34. Papendieck CM. Lymphangiomatosis and dermoepidermal disturbances of lymphangioadenodysplasias. Lymphology 2002;35:478-85.
35. Vercellio, Baraldini V, Coletti M, Santuari D. Strategies in early management of pure lymphatic malformations. Lymphology 2002;35:472-477.
36. Rosbotham JL, Brice GW, Child AH, Nunan TO, Mortimer PS, Burnand KG. Distichiasis-lymphoedema: clinical features, venous function and lymphoscintigraphy. Br J Dermatol. 2000;142:148-52.
37. Northrup KA, Witte MH, Witte CL. Syndromic classification of hereditary lymphedema. Lymphology 2003;36:162-89.
38. Greenlee R, Hoyme H, Witte M, Crowe P, Witte C. Developmental disorders of the lymphatic system. Lymphology 1993;26:156-168.
39. Aagenaes O, van der Hagen CB, Refsum S. Hereditary recurrent intrahepatic cholestasis from birth. Arch Dis Child. 1968;43:646-57.
40. Lee BB, Laredo J, Seo JM, Neville R: Treatment of Lymphatic Malformations. Chapter 29, Hemangiomas and Vascular Malformations. Mattassi, Loose, Vaghi (eds) Springer-Verlag Italia, 2009, Milan, Italy pp. 231-250
41. Lee BB: Statues of new approaches to the treatment of congenital vascular malformations (cvms) - single center experiences - (editorial review). Eur. J Vasc Endovasc Surg 2005;30(2):184-197.
42. Lee BB: Advanced management of congenital vascular malformation (CVM). International Angiology 21(3):209-213, September 2002.
43. Lee BB, Bergan JJ: Advanced management of congenital vascular malformations: a multidisciplinary approach. Cardiovasc Surg 2002;10(6):523-33.
44. Lee BB. Critical issues on the management of congenital vascular malformation. Annals Vasc Surg 2004;18(3):380-392.
45. Lee BB: Current concept of venous malformation (VM). Phlebolymphology 2003;43:197-203.
46. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003;37(3):533-8.
47. Lee BB, Mattassi R, Choe YH, Vaghi M, Ahn JM, Kim DI, et al. Critical role of duplex ultrasonography for the advanced management of a venous malformation (VM). Phlebology 2005; 20:28-37.
48. Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyun WS, et al: Management of arterial-venous shunting malformations (AVM) by surgery and embolosclero-therapy. A multidisciplinary approach. J. Vasc. Surg 2004;39(3):590-600.
49. Lee B B, Laredo J, Neville R. Arterio-venous malformation: how much do we know? Phlebology 2009;24:193-200
50. Lee, B.B., Laredo, J., Deaton, D.H., and Neville, R.F. Arteriovenous malformations: evaluation and treatment. In Handbook of Venous Disorders: Guidelines of the American Venous Forum, 3rd Edition; Gloviczki, P., Ed; A Hodder Arnold Ltd, 2009, London, UK.
51. Goldman MP, Fitzpatrick RE, Ruiz-Esparza J. Treatment of port-wine stains (capillary malformation) with the flashlamp-pumped pulsed dye laser. J Pediatr. 1993;122(1):71-7.
52. Berwald C, Salazard B, Bardot J, Casanova D, Magalon G. Port wine stains or capillary malformations: surgical treatment Ann Chir Plast Esthet. 2006;51(4-5):369-72.
53. Gloviczki P, Driscoll DJ. Klippel-Trenaunay syndrome: current management. Phlebology. 2007; 22: 291-298.
54. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73(1):28-36.
55. Lee BB, Bergan J. Gloviczki P, Laredo J, Loose DA, Mattassi R, Parsi K, Villavicencio JL, Zamboni P: Diagnosis and treatment of venous malformations - Consensus Document of the International Union of Phlebology (IUP)-2009. Int Angiol 2009;28(6):434-51.
56. Lee BB, Laredo J, Lee TS, Huh S, Neville R. Terminology and classification of congenital vascular malformations. Phlebology. 2007;22(6):249-52.
57. Belov S. Classification, terminology, and nosology of congenital vascular defects. In: Belov S, Loose DA, Weber J, eds. Vascular Malformations. Reinbek, Germany: Einhorn-Presse; 1989 pp.25-30.
58. Belov St. Classification of congenital vascular defects. Int Angiol 1990;9:141-146.
59. Kinmonth JB, Wolfe JH. Fibrosis in the lymph nodes in primary lymphoedema. Histological and clinical studies in 74 patients with lower-limb oedema. Ann R Coll Surg Engl. 1980;62(5):344-354.
60. Ferrell RE, Levinson KL, Esman JH, Kimak MA, Lawrence EC, Barmada MM, et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum. Mol. Genet. 1998;7:2073-2078.
61. Michelini S, Degiorgio D, Cestari M, et al. Clinical and genetic study of 46 Italian patients with primary lymphedema. Lymphology 2012; 45(1):3-12.
62. Brice G, Child AH, Evans A, Bell R, Mansour S, Mortimer P, et al. Milroy disease and the VEGFR-3 mutation phenotype. J. Med. Genet. 2005;42:98-102.
63. Ferrell RE, Baty CJ, Kimak Ma, Karlsson JM, Lawrence EC, Franke-Snyder M, et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet 2010;86: 943-8.
64. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Mortimer PS, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 2011:43;929-931.
65. Witte MH, Erickson R, Bernas M, et al. Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology 1998;31:145-55.
66. Ghalamkarpour A, Holnthoner W, Saharinen P, Boon L M, Vikkula M, et al. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J Med Genet 2009;46:399-404.
67. Erickson RP. Lymphedema-distichiasis and FOXC2 gene mutations. Lymphology. 2001;34(1):1-5.
68. Samlaska CP. Congenital lymphedema and distichiasis. Distichiasis- lymphedema. A hereditary syndrome of multiple congenital defects. Pediatr Dermatol. 2002;19(2):139-41.
69. Finegold DN, Kimak MA, Lawrence EC, Levinson KL, Cherniske EM, Pober BR, Dunlap JW, Ferrell RE. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet. 2001;15(10):1185-9.
70. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 2000;25:153-159.
71. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 2000;67:295-301.
72. Mangion J, Rahman N, Mansour S, Brice G, Rosbotham J, Mortimer P, et al. A gene for Lymphedema-distichiasis maps to 16q24.3. Am. J. Hum. Gen. 1999;65:427-432.
73. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 2000;67:1382-8.
74. Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Vikkula M et al. Mutations in the transcription factor gene SOX 18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am. J. Hum. Genet. 2003;72:1470-8.
75. Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Witte M, et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009;41:1272-4.
76. Connell F, Kalidas K, Ostergaard P, Brice G, Homfray T, Mortimer PS, et al. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia. Human Genetics. 2010;127:231-41.
77. Ostergaard P, Simpson MA, Brice G, Mansour S, Connell F, Mortimer PS, et al. Rapid identification of mutations in GJC2 in primary lymphoedema using whole exome sequencing combined with linkage analysis with delineation of the phenotype. J Med Genet. 2011:48:251-5.
78. Ostergaard P, Simpson M, Mendola A, Vasudevan P, Connell FC, Mortimer PS, et al. Mutations in KIF11 Cause Autosomal-Dominant Microcephaly Variably Associated with Congenital Lymphedema and Chorioretinopathy, Am. J. Hum. Gen. 2012; doi:10.1016/j.ajhg.2011.12.018.
79. Bos FL, Caunt M, Peterson-Maduro J, Planas-Paz L, Kowalski J, Karpanen T, et al. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ Res. 2011;109(5):486-91.
80. Bull LN, Roche E, Song EJ, Pedersen J, Knisely AS, van der Hagen CB, et al. Mapping of the Locus for Cholestasis-Lymphedema Syndrome (Aagenaes Syndrome) to a 6.6-cM Interval on Chromosome 15q Am J Hum Genet. 2000; 67(4):994-999.
81. Ferrell RE, Finegold DN. Research perspectives in inherited lymphatic disease: an update. Ann N Y Acad Sci 2008;1131:134-39.
82. Rockson SG. Secondary lymphedema: Is it a primary disease? Lymphatic Research and Biology 2008;6(2):63-64
83. Rockson SG. Diagnosis and management of lymphatic vascular disease J Am Coll Cardiol. 2008;52(10):799-806
84. Finegold D, Baty C, Knickelbein K, Perschke S, Noon S, et al. Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res 2008;18:232-2390.
85. Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med 2004; 4: 3448-53
86. Mellor RH, Hubert CE, Stanton AW, Tate N, Akhras V, Smith A, Burnand KG, Jeffery S, Mäkinen T, Levick JR, Mortimer PS. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation. 2010;17:281-296.
87. Lee BB, Laredo J: Contemporary role of lymphoscintigraphy: we can no longer afford to ignore! Editorial, Phlebology 2011;26:177-178
88. Lee BB: Chronic lymphedema, no more stepchild to modern medicine! Eur J Lymphol 2004;14(42):6-12.
89. Lee BB, Kim DI, Whang JH, Lee KW. Contemporary management of chronic lymphedema - personal experiences. Lymphology 2002;35:450-455
90. Lee BB: Current issue in management of chronic lymphedema: Personal Reflection on an Experience with 1065 Patients. Lymphology 2005;38:28-31.
91. Lee BB, Laredo J, Neville R, Loose D: Diagnosis and management of primary phlebolymphedema. Chapter 64. Section - XVI - Phlebolymphedema. LYMPHEDEMA: A Concise Compendium of Theory and Practice. Lee, Byung-Boong; Bergan, John; Rockson, Stanley G. (Eds.), 1st Edition, Springer-Verlag, London, UK, 2011, pp 537-546.
92. Lee BB, Andrade M, Bergan J, Boccardo F, Campisi C, Damstra R, Flour M, Gloviczki P, Laredo J, Piller N, Michelini S, Mortimer P, Villavicencio JL: Diagnosis and treatment of Primary Lymphedema - Consensus Document of the International Union of Phlebology (IUP)-2009. International Angiology 2010;29(5): 454-70.
93. Lee BB, Bergan, JJ: New clinical and laboratory staging systems to improve management of chronic lymphedema. Lymphology 2005;38(3):122-129.
94. Michelini S., Campisi C, Gasbarro V., Allegra C, Conte M., Cestari M., Molisso A., Cavezzi A., Mattassi R., Aiello A., Ricci M., Zanetti L. National guidelines on lymphedema. Lymphology 2007;55:238-242.
95. Michelini S., Failla A., Moneta G., Campisi C. Boccardo F. Clinical staging of lymphedema and therapeutical implications. Lymphology 2002;35:168-176.
96. Michelini S., Failla A., Moneta G. Lymphedema: epidemiology, disability and social costs. Lymphology 2002;35:169-171.
97. Michelini S., Failla A., Moneta G., Rubeghi V, Zinicola V, M. Cardone, et al. Lymphedema and occupational therapy. Lymphology 2007;55: 243-246.
98. Michelini S, Failla A, Moneta G, Zinicola V, Romaldini, Puglisi D. International classification of lymphedema functioning and disability evaluation. Eur J Lymphology. 2007; 17(51): 16-19.
99. Stemmer R. A clinical symptom for the early and differential diagnosis of lymphedema. Vasa. 1976;5(3):261-2.
100. Kim YW, Do YS, Lee SH, Lee BB: Risk Factors for Leg Length Discrepancy in Patients with Congenital Vascular Malformation. J Vasc Surg. 2006;44:545-53.
101. Mattassi R, Vaghi M: Vascular bone syndrome-angiosteodystrophy: Current Concept. Phlebology. 2007; 22: 287-290.
102. Tassenoy A, De Mey J, De Ridder F, Van Schuerbeeck P, Vanderhasselt T, Lamote J, et al. Postmastectomy lymphoedema: different patterns of fluid distribution visualised by ultrasound imaging compared with magnetic resonance imaging. Physiotherapy. 2011;97(3):234-43.
103. Case TC, Witte CL, Witte MH, et al. Magnetic resonance imaging in human lymphedema: comparison with lymphangioscintigraphy. Magn Reson Imaging 1992;10:549-558.
104. Haaverstad R, Nilsen G, Myhre HO, Saether OD, Rinck PA. The use of MRI in the investigation of leg oedema. Eur J Vasc Surg 1992; 6(2):124-29.
105. Haaverstad R, Nilsen G, Rinck PA, Myhre HO. The use of MRI in the diagnosis of chronic lymphedema of the lower extremity. Int Angiol 1994;13(2):115-18.
106. Hadjis N. S., Cam D. H., Banks L, Pflugl J. J. The Role of CT in the Diagnosis of Primary Lymphedema of the Lower Limb. AJR 1985;144:361-364
107. Gamba JL, Silverman PM, Ung D, Dunnick NA, Korobkin M. Primary lower extremity lymphedema: CT diagnosis. Radiology 1983;149:218-21
108. Szuba A, Strauss W, Sirsikar SP, Rockson SG. Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity. Nucl Med Commun. 2002;23:1171-5.
109. Solari N, Gipponi M, Stella M, Queirolo P, di Somma, et al: Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma. Melanoma Research 2009;19(4):243-251.
110. Cambria RA, Gloviczki P, Naessens JM, Wahner HW. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities. J Vasc Surg. 1993; 18:773-82.
111. Lohrmann C, Foeldi E, Speck O, Langer M. High-resolution MR lymphangiography in patients with primary and secondary lymphedema. AJR Am J Roentgenol. 2006;187(2):556-61.
112. Lohrmann C, Felmerer G, Foeldi E, Bartholomä JP and Langer M. MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstructions of lymphatic vessels. Microvascular Research 2008;76(1): 42-45.
113. Allegra C, Sarcinella R, Bartolo M Jr. Morphologic and functional changes of the microlymphatic network in patients with advancing stages of primary lymphedema. Lymphology. 2002;35(3):114-20.
114. Bollinger A, Jäger K, Sgier F, Seglias J. Fluorescence microlymphography. Circulation. 1981;64(6):1195-2000
115. Unno N, Nishiyama M, Suzuki M, Yamamoto N, Inuzuka K, Sagara D, Tanaka H, Konno H. Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Vasc Endovasc Surg. 2008;36(2):230-6.
116. Proulx ST, Luciani P, Derzsi S, Rinderknecht M, Mumprecht V, Leroux JC, et al. Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res. 2010;15;70(18):7053-62.
117. Partsch H, Urbanek A, Wenzel-Hora B. The dermal lymphatics in lymphoedema visualized by indirect lymphography. Br J Dermatol. 1984;110(4):431-8.
118. Lee BB, Mattassi R, Kim BT, Kim DI, Ahn JM, Choi JY. Contemporary diagnosis and management of venous and AV shunting malformation by whole body blood pool scintigraphy. Int. Angiol. 2004;23(4):355-67.
119. Deltombe T, Jamart J, Recloux S, Legrand C, Vandenbroeck N, Theys S, et al. Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology 2007; 40:26-34
120. Sergi G, Bussolotto M, Perini P, Calliari I, et al. Accuracy of bioelectrical bioimpedance analysis for the assessment of extracellular space in healthy subjects and in fluid retention states. Ann Nutr Metab 1994;38(3):158-65
121. Criado E, Farber MA, Marston WA, Daniel PF, Burnham CB, Keagy BA. The role of air plethysmography in the diagnosis of chronic venous insufficiency. J Vasc Surg. 1998;27(4):660-70.
122. Brorson H. Liposuction in arm lymphedema treatment. Scand J Surg. 2003;92(4):287-95.
123. Brorson H. Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer. Acta Oncol. 2000;39(3):407-20.
124. Antignani PL, Benedetti Valentini F, Aluigi L, baroncelli T et al. Guidelines of Italian Society for vascular Investigation. Int Angiol. 2012; 5:1-78
125. Gniadecka M. Localization of dermal edema in lipoder-matosclerosis, lymphedema, and cardiac insufficiency. J Am Acad Dermatol 1996;35: 37-41
126. Consensus document of the International Society of Lymphology Executive Committee. The diagnosis and treatment of peripheral lymphedema. Lymphology 1995;28(3):113-17.
127. Werner GT, Rodiek SO. Value of nuclear magnetic resonance tomography in leg edema of unknown origin. Preliminary report. Z Lymphol 1993;17(1):2-5.
128. Gloviczki P, Calcagno D, Schirger A, et al. Noninvasive evaluation of the swollen extremity: experiences with 190 lymphoscintigraphy examinations. J Vasc Surg. 1989;9:683-9; discussion 690.
129. Brautigam P, Foldi E. Schaiper I, Krause T, Vanscheidt W, Moser E. Analysis of lymphatic drainage in various forms of leg edema using two compartment lymphoscintigraphy. Lymphology 1998;31:43-55.
130. Olszewski WL. Lymphoscintigraphy helps to differentiate edema of various etiologies (inflammatory, obstructive, posttraumatic, venous). Lymphology 2002;35:233-235.
131. Guidelines 6.2.0. on lymphoscintigraphy and lymphangiography. page 647. Chapter 58, Handbook of Venous Disorders: Guidelines of the American Venous Forum, 3rd Edition; Gloviczki, P., Ed; A Hodder Arnold: London, UK. 2009.
132. Burnand KM et al, Popliteal node visualization during standard pedal lymphoscintigraphy for a swollen limb indicates impaired lymph drainage. AJR 2011; 197:1443-8.
133. Bellini C, Boccardo F, Campisi C, Villa G, Taddei G, Traggiai C, Bonioli E. Lymphatic dysplasias in newborns and children: the role of lymphoscintigraphy. J Pediatr. 2008;152(4):587-9.
134. uami, H, Chang, D Skoracki R, Yamada, K and Kimata, Y Using indocyanine green fluorescent lymphography to demonstrate lymphatic architecture. Journal of Lymphoedema 2012;7(2):25-29
135. Yamamoto T Matsuda, N Doi, K et al The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphoedema patients secondary to cancer treatment. Plastic and Reconstructive Surgery 2011;128(31):4e-21e.
136. Campisi C, Bellini C, Eretta C, Zilli A, da Rin E, Davini D, Bonioli E, Boccardo F. Diagnosis and management of primary chylous ascites. J Vasc Surg. 2006;43(6):1244-8.
137. Boccardo F, Bellini C, Eretta C, Pertile D, Da Rin E, Benatti E, Campisi M, Talamo G, Macciò A, Campisi C, Bonioli E, Campisi C. The lymphatics in the pathophysiology of thoracic and abdominal surgical pathology: immunological consequences and the unexpected role of microsurgery. Microsurgery. 2007;27(4):339-45.
138. Gasbarro V, Michelini S, Antignani PL, Tsolaki E, Ricci M, Allegra C. The CEAP-L classification for lymphedemas of the limbs: the Italian experience. Int Angiol. 2009;28(4):315-24.
139. von der Weid PY, Rahman M, Imtiaz MS, van Helden DF. Spontaneous transient depolarizations in lymphatic vessels of the guinea pig mesentery: pharmacology and implication for spontaneous contractility. Am J Physiol Heart Circ Physiol. 2008;295(5):1989-2000.
140. Michelini S, Campisi C, Cavezzi A, Boccardo F, Failla A, Moneta G. National epidemiologic study of lymphedema. Minerva Cardioangiol. 1998;46(10):393-4.
141. Casley-Smith, Judith R, Mason MR, Morgan RG, Casley-Smith JR. Complex physical therapy of the lymphedematous leg. Int J Angiol 1995;4:134-142.
142. Johansson K, Albertsson M, Ingvar C, Ekdahl C. Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema. Lymphology. 1999;32(3):103-10.
143. Szolnoky G, Mohos G, Dobozy A, Kemeny L: Manual lymphdrainage reduces trapdoor effect in subcutaneous pedicle flaps. Int J Dermatol 2006;45:1468-70
144. Kasseroller RG. The Vodder School: the Vodder method. Cancer. 1998;15(83):2840-2.
145. Foldi E, Foldi M, Weissletter H. Conservative treatment of lymphedema of the limbs. Angiology 1985;36:171-180.
146. Adams KE, Rasmussen JC, Darne C, Tan IC, Aldrich MB, Marshall MV, et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression devicetreatment of lymphedema. Biomed Opt Express. 2010;15(1): 114-125.
147. Stout N, Partsch H, Szolnoky G, Forner-Cordero I, Mosti G, Mortimer P, et al. Chronic edema of the lower extremities: international consensus recommendations for compression therapy clinical research trials. Int Angiol. 2012;31(4):316-29.
148. Hwang JH, Kim TU, Lee KW, Kim DI, Lee BB: Sequential intermittent pneumatic compression therapy in lymphedema. J. Korean Acad. of Rehab. Med. 1997;21(1):146-153.
149. Pflug JJ. Intermittent compression in the management of swollen legs in general practice. Lancet 1975;215:69-76.
150. Partsch H, Stout N, Forner-Cordero I, Flour M, Moffatt C, Szuba A, et al. Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema. Proposals from an expert group. Int Angiol. 2010;29(5):442-53.
151. Lamprou DA, Damstra RJ, Partsch H. Prospective, randomized, controlled trial comparing a new two-component compression system with inelastic multicomponent compression bandages in the treatment of leg lymphedema. Dermatol Surg. 2011;37(7):985-91.
152. Damstra RJ, Partsch H. Prospective, Randomized Controlled Trial Comparing the Effectiveness of Adjustable Compression Velcro-Wraps versus Inelastic Multilayer Compression Bandages in the Initial Treatment of Leg Lymphedema. J Vasc Surg: Venous and Lym Dis 2013;1:13-9
153. Partsch H, Damstra RJ, Mosti G. Dose finding for an optimal compression pressure to reduce chronic edema of the extremities. Int Angiol. 2011;30(6):527-33.
154. Damstra RJ, Partsch H. Compression therapy in breast cancer-related lymphedema: A randomized, controlled comparative study of relation between volume and interface pressure changes. J Vasc Surg. 2009;49(5):1256-63.
155. Mosti G, Picerni P, Partsch H. Compression stockings with moderate pressure are able to reduce chronic leg oedema. Phlebology. 2012;27(6):289-96
156. Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens MR. Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol.2010;149(1):3-9.
157. McNeely ML, Peddle CJ, Yurick JL, Dayes IS, Mackey JR. Conservative and dietary interventions for cancer-related lymphedema: a systematic review and metaanalysis. Cancer. 2011;117(6):1136-48.
158. Devoogdt N, Christiaens MR, Geraerts I, Truijen S, Smeets A, Leunen K, Neven P, Van Kampen M. Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trial. BMJ. 2011 Sep 1;343:d5326
159. Moskovitz AH, Anderson BO, Yeung RS, Byrd DR, Lawton TJ, Moe RE. Axillary web syndrome after axillary dissection. Am J Surg 2001;181(5):434-9.
160. Lauridsen MC, Christiansen P, Hessov I. The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol 2005; 44(5):449-57.
161. Johansson K, Ingvar C, Albertsson M, Ekdahl C. Arm lymphoedema, shoulder mobility and muscle strenght after breast cancer treatment - a prospective 2-year study. Adv Phys Ther 2001;3:55-66.
162. Olszewski WL, Jain P, Ambujam G, Zaleska M, Cakala M, Gradalski T. Tissue fluid pressure and flow during pneumatic compression in lymphedema of lower limbs. Lymphat Res Biol. 2011;9(2):77-83.
163. Mayrovitz HN. Interface pressures produced by two different types of lymphedema therapy devices. Phys Ther. 2007;87(10):1379-88.
164. Guidelines 6.3.0. on medical and physical therapy. page 655. Chapter 59, Handbook of Venous Disorders: Guidelines of the American Venous Forum, 3rd Edition; Gloviczki, P., Ed; A Hodder Arnold: London, UK. 2009.
165. Roztocil K, Pretovsky I, Olivia I. The effects of hydroethylrutosides on capillary filtration rate in the lower limbs of man. Eur J Clin Pharm 1993;11:435-438.
166. Clement DL. Management of venous edema: Insights from an international task force. Angiology 2000;51:13-17.
167. Knight KR, Khazanchi RK, Pederson WC et al. Coumarin and 7-hydroxycoumarin treatment of canine obstructive lymphoedema. Clinic Sci. 1989;77(1): 69-76.
168. Casley-Smith JR, Morgan RG, Piller NB. Treatment of lymphedema of the arms and legs with 5,6-benzo-alpha-pyrone. N Engl J Med 1993;329:1158-1163.
169. Burgos A, Alcaide A, Alcoba C et al. Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Lymphology 1999;32:3-10.
170. Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ, Levitt R, Tschetter LK, Windschitl H. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999; 340(5):346-350.
171. Piller NB, Morgan RG, Casley-Smith JR. A double-blind, cross-over trial of O-(beta hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs. Br J Plast Surg. 1988;41:20-27.
172. Badger C, Preston N, Seers K, Mortimer P. Benzo-pyrones for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev. 2004;(2):CD003140.
173. Michelini S, Campisi C, Failla A, Boccardo F, Moneta G. Combination treatment of lymphedema; Our experiences. Minerva Cardioangiol. 1998;46(10):395-6.
174. Campisi C, Boccardo F., Macciò A., Zilli A., Michelini S. Natural coumarins in lymphatic microsurgery. Lymphology 2002;35:635-639.
175. Michelini S., Failla A., Moneta G., Cardone M., Fiorentino A., Michelotti L., Galluccio A. Shockwave therapy in lymphedema patients: preliminary study. Lymphology 2007;55: 235-237.
176. Farinola N, Piller N. Pharmacogenomics: its role in reestablishing coumarin as treatment for lymphedema Lymphat Res Biol. 2005;3(2):81-6.
177. Olszewski WL. The treatment of lymphedema of the extremities with microsurgical lympho-venous anastomoses. Int Angiol. 1988;7(4):312-21.
178. Becker C, Hidden G, Godart S, Maurage H, Pecking A. Free lymphatic transplantation. European J. Lymphol. 1991;6(2): 75-80.
179. Gloviczki P. Review. Principles of surgical treatment of chronic lymphoedema. Int Angiol. 1999;18(1):42-6.
180. Becker C, Hidden G, Pecking A et al. Transplantation of lymphnodes: an
181. Kim DI, Lee BB, Huh S, Lee SJ, Hwang JH, Kim YI. Excision of subcutaneous tissue and deep muscle fascia for advanced lymphedema. Lymphology 1998;31:190-194.
182. Auchincloss H. New operation for elephantiasis. Puerto Rico J Publ Health & Trop. Med 1930;6:149-52.
183. Homans J. The treatment of elephantiasis of the legs. N Engl J Med 1936;215:1099-1103.
184. Sistrunk WE. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg. 1998;102(4):1058-67; discussion 1068.
185. Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg. 1998;102(4):1058-67; discussion 1068.
186. Brorson H, Svensson H, Norrgren K, Thorsson O. Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport. Lymphology. 1998;31(4):156-72.
187. Lee BB, Villavicencio JL: Primary lymphedema and lymphatic malformation: are they the two sides of the same coin? Eur J Vasc Endovasc Surg 2010;39:646-653
188. Lee BB, Laredo J, Neville R:. Primary lymphedema as a truncular lymphatic malformation. Chapter 51, Section XI - Lymphedema and Congenital Vascular Malformation Page 419-426, LYMPHEDEMA: A Concise Compendium of Theory and Practice. Lee, Byung-Boong; Bergan, John; Rockson, Stanley G. (Eds.), 1st Edition, Springer-Verlag, London, UK, 2011
189. Lee BB, Laredo J, Neville R, Mattassi R: Primary lymphedema and Klippel-Trenaunay syndrome. Chapter 52. Section XI - Lymphedema and Congenital Vascular Malformation. Page 427-436, LYMPHEDEMA: A Concise Compendium of Theory and Practice. Lee, Byung-Boong; Bergan, John; Rockson, Stanley G. (Eds.), 1st Edition, Springer-Verlag, London, UK, 2011
190. Lee BB, Laredo J. Classification of congenital vascular malformations: the last challenge for congenital vascular malformations. Phlebology. 2012;27(6):267-9.
191. Campisi C, Da Rin E, Bellini C, Bonioli E, Boccardo F. Pediatric lymphedema and correlated syndromes: role of microsurgery. Microsurgery. 2008;28(2):138-42.
192. Campisi C, Boccardo F. Vein graft interposition in treating peripheral lymphoedemas. Handchir Mikrochir Plast Chir. 2003;35(4):221-4.
193. Campisi C, Bellini C, Campisi C, Accogli S, Bonioli E, Boccardo F. (2010). Microsurgery for lymphedema: clinical research and long-term results. Microsurgery, vol. 30(4), p. 256-260.
194. Campisi C, Boccardo F. Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg. 2004;28(6):609-13.
195. Lee BB, Laredo J, Neville R: Current Status of Lymphatic Reconstructive Surgery for Chronic Lymphedema: It Is Still an Uphill Battle! Int J Angiol 2011;20(2): 73-79.
196. Lee BB, Laredo J, Neville R: Current dilemma with controversy. Chapter 45. Section IX - Surgical treatment - Reconstructive Surgery Section, Page 381-386, LYMPHEDEMA: A Concise Compendium of Theory and Practice. Lee, Byung-Boong; Bergan, John; Rockson, Stanley G. (Eds.), 1st Edition, Springer-Verlag, London, UK, 2011
197. Lee BB, Laredo J, Neville R: Reconstructive surgery for chronic lymphedema: a viable option, but. Vascular 2011;19(4):195-205.
198. Lee BB, Laredo J, Neville R: Current Status of Lymphatic Reconstructive Surgery for Chronic Lymphedema: It Is Still an Uphill Battle! Int J Angiol 2011;20(2): 73-79.
199. Babb RR, Spittell JA Jr, Martin WJ, Schirger A. Prophylaxis of recurrent lymphangitis complicating lymphedema. JAMA. 1966;195(10):871-3.
200. Campisi C, Boccardo F, Campisi CC, Ryan M. Reconstructive microsurgery for lymphedema: while the early bird catches the worm, the late riser still benefits. J Am Coll Surg. 2013;216:506-7
201. Papendieck, CM.: Lymphatic dysplasias in Pediatrics. Inter Angiol 1999;18:6-9
202. Pardini M, Bonzano L, Roccatagliata L, Boccardo F, Mancardi G, Campisi C. Functional magnetic resonance evidence of cortical alterations in a case of reversible congenital lymphedema of the lower limb: a pilot study. Lymphology 2007;40 (1): 19-25.
203. Kim DI, Lee BB, Huh S, Lee SJ, Hwang JH, Kim YI. Excision of subcutaneous tissue and deep muscle fascia for advanced lymphedema. Lymphology 1998;31:190-194.
204. Dellon Al, Hoopes JE. The Charles procedure for primary lymphedema. Plas. & Reconstr. Surg 1977;60:589-92.
205. Lee BB, Laredo J, Neville R: Contemporary indication and controversy on excisional surgery. Chapter 49, Section X - Surgical treatment - Excisional/Cytoreductive Surgery Page 403-408, LYMPHEDEMA: A Concise Compendium of Theory and Practice. Lee, Byung-Boong; Bergan, John; Rockson, Stanley G. (Eds.), 1st Edition, Springer-Verlag, London, UK, 2011
206. Guidelines 6.4.0. on medical and physical therapy. page 663. Chapter 60, Handbook of Venous Disorders: Guidelines of the American Venous Forum, 3rd Edition; Gloviczki, P., Ed; A Hodder Arnold: London, UK. 2009.
207. Fife CE, Carter MJ. Lymphedema in the morbidly obese patient: unique challenges in a unique population. Ostomy Wound Manage. 2008;54:44-56.
208. Dean SM, Zirwas MJ, Horst, AV. Elephantiasis nostras verrucosa: An institutional analysis of 21 cases. Journal of the American Academy of Dermatology, 2011;64(6):1104-1110.
209. Femandes LB, Fleury Jr LFF. Comparative dermatology: elephantiasis nostra in verrucous form comparable to coral. Anais brasileiros de dermatologia. 2011;86(4), 825-826.
210. Iwao, F., Sato-Matsumura, K. C, Sawamura, D., & Shimizu, H. Elephantiasis nostras verrucosa successfully treated by surgical debridement. Dermatologic surgery. 2011;30(6): 939-941.
211. Kaposi M. Leçons sur les Maladies de la Peau, Masson, Paris, 1881. French translation of Pathologie und Therapie der Hautkrankheiten in Vorlesungen, Wien-Lepzig, Wien, 1880. pp 125-127.
212. de Godoy JMP, Azoubel LM, de Fátima Guerreiro Godoy M. Surgical treatment of elephantiasis of the feet in congenital lymphedema to facilitate the use of a compression mechanism. Int J Gen Med. 2010;3:115-8.
213. Berngard SC, Narayanan V Elephantiasis nostras verrucosa of the pannus. J Gen Intern Med. 2011;26(7):810-12.
214. Mendoza N, Li A, Gill A, Tyring S. Filariasis: diagnosis and treatment. Dermatol Then 2009;22(6):475-90.
215. Korevaar DA, Visser BJ: Podoconiosis, a neglected topical disease. Neth J Med 2012;70:210-14
216. Davey G, Tekola F, Newport MJ. Podoconiosis: noninfectious geochemical elephantiasis. Trans R Soc Trop Med Hyg. 2007;101(12):1175-80.
217. Padmasiri E, Montresor A, Biswas G, Desilva N. Controlling lymphatic filariasis and soil-transmitted helminthiasis together in South Asia: opportunities and challenges. Trans R Soc Trop Med Hyg. 2006;100(9):807-10.
218. Andrade, M. Lymphatic Filariasis. Problems in General Surgery 2001;18:79-84.
219. Olszewiski, W. Infection in Lymphedema: A Concise Compendium of Theory and Practice. Lee BB, Bergan J, Rockson SG (eds.), Springer London, 2011, pp 207-216
220. Prica S, Donati OF, Schaefer DJ, Peltzer J. Genital elephantiasis: reconstructive treatment of penoscrotal lymphoedema with a myocutaneous M. gracilis flap. Experiences from a District Hospital in Ethiopia. Handchir Mikrochir Plast Chir. 2008;40(4):272-8.
221. Tenhagen M, Lodewijk L, Cense HA, Busch ORC. Clinical appearance and management of massive localized lymphedema in morbidly obese patients: report of 2 cases. Updates Surg. 2012 Oct 16.
222. Champaneria MC, Workman A, Kao H, Ray AO, Hill M. Reconstruction of massive localised lymphoedema of the scrotum with a novel fasciocutaneous flap: A rare case presentation and a review of the literature. JPRAS 2013;66(2):281-6
223. Damstra RJ, Voesten HGJM, Klinkert P, Brorson H. Circumferential suction-assisted lipectomy for lymphoedema after surgery for breast cancer. Br J Surg. 2009;96(8):859-64.
224. Brorson H, Fressero C, Ohlin k, Svensson B. Liposuction normalizes elephantiasis of the leg - a prospective study with a 6 year follow-up. Lymphology. 2010;43:105-7.
225. Brorson H, Ohlin K, Olsson G, Nilsson M. Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images. Lymphat Res Biol. 2006;4(4): 199-210.
226. Zouboulis CC, Biczó S, Gollnick H, Reupke HJ, Rinck G, Szabó M, et al. Elephantiasis nostras verrucosa: beneficial effect of oral etretinate therapy. Br J Dermatol. 1992;127(4):411-6.
227. Polat M, Sereflican B. A case of elephantiasis nostras verrucosa treated by acitretin. J Drugs Dermatol. 2012;11(3):402-5.
228. Saurat JH. [Acitretin (RO 10-1670). A successor of etretinate?]. Ann Dermatol Venereol. 1988;115(8):849-52.
229. Bunke N, Brown K, Bergan J. Phlebolymphemeda: usually unrecognized, often poorly treated. Perspect Vasc Surg Endovasc Then 2009;21(2):65-68.
230. Weissleder H, Waldermann F, Kopf W. Familial venous dysplasia and lymphedema. Z Lymphoil. 1996;20(1):36-39.
231. Mortimer PS. Evaluation of lymphatic function: abnormal lymph drainage in venous disease. Int Angiol. 1995;14(3 Suppl 1):32-35.
232. Klippel M, Trenaunay J. Du noevus variqueux et osteohypertrophique. Arch Gén Méd. 1900;3:641-672
233. Lee BB, Villavicencio L. General considerations: congenital vascular malformations. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia: Saunders Elsevier; 2010:1046-1064; Section 9. Arteriovenous Anomalies.
234. Lee BB. Invited Editorial: Klippel-Trenaunay syndrome: is this term still worthy to use? Acta Phlebol 2012;13:83-5
235. Raju S, Furrh JB 4th, Neglén P. Diagnosis and treatment of venous lymphedema. J Vasc Surg. 2012 Jan;55(1): 141-9.
236. Chopra K, Tadisina KK, Brewer M, Holton LH, Banda AK, Singh DP. Massive Localized Lymphedema Revisited: A Quickly Rising Complication of the Obesity Epidemic. Ann Plast Surg. 2013 May 30. [Epub ahead of print] PubMed PMID:23722582.
237. Raju S, Owen S Jr, Neglen P. Reversal of abnormal lymphoscintigraphy after placement of venous stents for correction of associated venous obstruction. J Vasc Surg. 2001;34(5): 779-784.
238. Szuba A, Razavi M, Rockson SG. Diagnosis and treatment of concomitant venous obstruction in patients with secondary lymphedema. J Vasc Interv Radiol. 2002;13(8):799-803.
239. Bull RH, Gane JN, Evans JE, Joseph AE, Mortimer PS. Abnormal lymph drainage in patients with chronic venous leg ulcers. J Am Acad Dermatol. 1993;28(4):585-590.
240. Silva JH, Janeiro-Perez MC, Barros N, Vieira-Castiglioni ML, Novo NF, Miranda F. Venouslymphatic disease: lymphoscintigraphic abnormalities in venous ulcers. J Vasc Bras. 2009;8(1):33-42.
241. Franzeck UK, Haselbach P, Speiser D, Bollinger A. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency. Yale J Biol Med. 1993;66(1):37-46.
242. Bollinger A, Partsch H, Wolfe JHN. The Initial Lymphatics. Thieme Stratton Inc New York, 1985
243. Tiedjen KU. Detection of lymph vessel changes in venous diseases of the leg using imaging procedures. Z Lymphol. 1989;13(2):83-87.
244. Pannier F, Hoffmann B, Stang A, Jöckei K.-H, Rabe E. Prevalence of Stemmer's sign in the general population. Results from the Bonn Vein Study. Phlebologie 2007; 36: 289-292
245. Lee BB, Baumgartner I, Berlien HP, Bianchini G, Burrows P, Do YS, Ivancev K, Kool LS, Laredo J, Loose DA, Lopez-Gutierrez JC, Mattassi R, Parsi K, Rimon U, Rosenblatt M, Shortell C, Simkin R, Stillo F, Villavicencio L, Yakes W. Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management. Int Angiol. 2013 Feb;32(1):9-36.
246. Ziyeh S, Spreer J, Rossler J, Strecker R, Hochmuth A, et al. Parkes Weber or Klippel-Trenaunay syndrome? Non-invasive diagnosis with MR projection angiography. Eur Radiol. 2004; 14(11):2025-2029.
247. Courivaud D, Delerue A, Delerue C, Boon L, Piette F, Modiano P. Familial case of Parkes Weber syndrome. Ann Dermatol Venereol. 2006;133(5):445-7.
248. Lee BB, Laredo J, Lee SJ, Huh SH, Joe JH, Neville R. Congenital vascular malformations: general diagnostic principles. Phlebology. 2007;22(6):253-7.
249. Vollmar JF, Voss E. Vena marginalis laterlis persistens - die vergessene Vene der Angiologen. Vasa. 1979;8:192-4.
250. Kim YW, Lee BB, Cho JH, Do YS, Kim DI, Kim ES. Haemodynamic and clinical assessment of lateral marginal vein excision in patients with a predominantly venous malformation or the lower extremity. Eur J Vasc Endovasc Surg. 2007;33(1):122-127.
251. Lee BB. Marginal vein is not a simple varicose vein:it is a silent killer! Review. Damar Cer Derg 2013;22(1): 4-14.
252. Mattassi R, Vaghi M: Management of the marginal vein: current issues. Phlebology 2007; 22: 283-286
253. Lee BB, Laredo J, Neville R: Embryological background of truncular venous malformation in the extracranial venous pathways as the cause of chronic cerebrospinal venous insufficiency. Int Angiol 2010;29(2):95-108
254. Lee BB. Venous embryology: the key to understanding anomalous venous conditions. Phlebolymphology. 2012;19(4):170-181.
255. Loose DA. Contemporary treatment of congenital vascular malformations. In: Dieter RS, Dieter RA Jr, Dieter RA III, eds. Peripheral Arterial Disease. New York: McGrawHill Medical; 2009. pp.1025-1040.
256. Loose DA. Surgical management of venous malformations. Phlebology. 2007;22(6):276-282.
257. Loose DA. Surgical treatment of predominantly venous defects. Semin Vasc Surg. 1993;6(4):252-259.
258. Lee BB, Laredo J, Kim YW, Neville R. Congenital vascular malformations: general treatment principles. Phlebology. 2007;22(6):258-263.
259. www.who.int/whosis/icd10/
260. Allen, EV, EA Hines. Lipedema of the legs: a syndrome characterized by fat legs and orthostatic edema. Mayo Clin. Proc 1940:15:184-7.
261. Földi E, Földi M. [Das Lipödem] in Földi M, Kubik S eds, Lehrbuch der Lymphologie, 5nd edn, Chapt 9. München-Jena:Gustav Fischer, 2002:449-58.
262. Langendoen SI, Habbema L, Nijsten TEC, Neumann HAM. Lipoedema: from clinical presentation to therapy. A review of the literature. Br J Dermatol 2009:161:980-6.
263. Fife CE, Maus EA, Carter MJ. Lipedema a frequently misdiagnosed and misunderstood fatty deposition syndrome. Adv Skin Wound Care. 2010;23:81-92
264. Forner-Cordero I, Szolnoky G, Forner-Cordero A, Kemény L. Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome - systematic review. Clin Obstetr. 2012;2:86-95.
265. Chen S, Hsu SD, Chen TM, Wang HJ. Painful fat syndrome in a male patient. Br J Plast Surg 2004; 57: 282-6.
266. Siems W, Grune T, Voss P, Brenke R. Anti-fibrosclerotic effects of shock wave therapy in lipedema and cellulite. Biofactors 2005; 24: 275-82.
267. Bano G, Mansour S, Brice G, Ostergaard P, Mortimer PS, Jeffery S, Nussey S. Pit-1 mutation and lipoedema in a family. Exp Clin Endocrinol Diabetes 2010;118:377-80.
268. Child AH, Gordon KD, Sharpe P, Brice G, Ostergaard P, Jeffery S, et al. Lipoedema: an inherited condition. Am J Med Genet Part A 2009;152:970-6.
269. Suga H, Araki J, Aoi N, Kato H, Higashino T, Yoshimura K. Adipose tissue remodeling in lipedema: adipocyte death and concurrent regeneration. J Cutan Pathol 2009;36:1293-8.
270. Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol. 2010; 88:33-39).
271. Berry R, Rodehoffer MS. Characterization of the adipocyte cellular lineage in vivo. Nat Cell Biol. 2013;15:302-308)
272. Schmeller W, Hartwig D: Lipedema and congenital analbuminemia: a rare combination] LymphForsch 2012;16:58-63.
273. Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, Oliver G. Lymphatic vascular defects promoted by Proxl haploinsufficiency cause adult-onset obesity. Nat Genet. 2005;37:1072-1081.
274. Zampell JC, Aschen S, Weitman ES, Yan A, Elhadad S, De Brot M, Mehrara BJ. Adipogenesis in response to lymphatic fluid stasis is associated with a marked mononuclear cell inflammatory response. Plast Reconstr Surg. 2012;129:825-834.
275. Harwood CA, Bull RH, Evans J, Mortimer PS. Lymphatic and venous function in lipedema. Br J Dermatol. 1996; 134:1-6.
276. Meier-Vollrath I, Schneider W, Schmeller W: Das Lipödem: neue Möglichkeiten der Therapie. Schweiz Med Forum 2007:7:150-5.
277. Schingale FJ. Lipoedema. In: Lymphoedema, Lipoedema: A guide for those effected. Schlüttersche: Hannover, 2003, pp 64-71.
278. Herpertz U. Adipositas-Diagnostik in der Lymphologie. Lymph Forsch 2009:13:90-3
279. Streeten DH. Idiopathic edema. Pathogenesis, clinical features, and treatment. Endocrinol Metab Clin North Am 1995:24:531-47.
280. Szolnoky G, Nagy N, Kovács RK, Dósa-Racz E, Szabó A, Bársony K, Balogh M, Kemény L. Complex decongestive physiotherapy decreases capillary fragility in lipedema. Lymphology 2008:41:161-6.
281. Szolnoky G, Nemes A, Gavallér H, Forster T, Kemény L. Lipoedema is associated with increased aortic stiffness. Lymphology. 2012;45:71-9.
282. Schmeller W, Meier-Vollrath I. Schmerzen beim Lipödem. Versuch einer Annäherung. Lymph Forsch 2008;12(1):7-11.
283. Szolnoky G, Varga E, Varga M, Dósa-Racz É, Kemény L. Complex decongestive physiotherapy decreases pain intensity in lipedema. Lymphology 2011;44:178-82.
284. Naouri M, Samimi M, Atlan M, Perrodeau E, Vallin C, Zakine G et al. High resolution cutaneous ultrasonography to differentiate lipoedema from lymphoedema. Br J Dermatol 2010; 163:296-301.
285. Monnin-Delhom ED, Gallix BP, Achard C, Bruel JM, Janbon C. High resolution unenhanced computed tomography in patients with swollen legs. Lymphology. 2002;35:121-8.
286. Dimakakos PB, Stefanopoulos T, Antoniades P. MRI and ultrasonographic findings in the investigation of lymphedema and lipedema. Int Surg 1997:82:411-6.
287. Brauer WJ. Altersbezogene Funktionslymphszintigraphie beim Lipödem und Lipolymphödem. Lymph Forsch 2000;4: 74-7.
288. Amann-Vesti BR, Franzeck UK, Bollinger A. Microlymphatic aneurysms in patients with lipedema. Lymphology 2000:134:170-5.
289. Lohrmann C, Foeldi E, Langer M. MR imaging of the lymphatic system in patients with lipedema and lipolymphedema. Microvasc Res 2009:77:335-9.
290. Deri G, Weissleder H. Vergleichende prä- und posttherapeutische Volumenmessungen in Beinsegmenten beim Lipödem. Lymph Forsch 1997;1:35-7.
291. Szolnoky G, Borsos B, Bársony K, Balogh M, Kemény L. Complete decongestive physiotherapy of lipedema with or without pneumatic compression: a pilot study. Lymphology 2008;41:50-2.
292. Flour M, Clark M, Partsch H, Mosti G, Uhl JF, Chauveau M, Cros F, Gelade P, Bender D, Andriessen A, Schuren J, Cornu-Thénard A, Arkans E, Milic D, Benigni JP, Damstra R, Szolnoky G, Schingale FJ. Dogmas and Controversies in Compression Therapy. Report of an International Compression Club (ICC) meeting, Brussels. Int Wound J 2012 Jun 21
293. Schmeller W, Hueppe M, Meier-Vollrath I. Tumescent liposuction in lipoedema yields good long-term results. BrJ Dermatol. 2012;166:161-8.